Cargando…

A View Beyond HbA1c: Role of Continuous Glucose Monitoring

Hemoglobin A1C (HbA1c) is used as an index of average blood glucose measurement over a period of months and is a mainstay of blood glucose monitoring. This metric is easy to measure and relatively inexpensive to obtain, and it predicts diabetes-related microvascular complications. However, HbA1c pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chehregosha, Haleh, Khamseh, Mohammad E., Malek, Mojtaba, Hosseinpanah, Farhad, Ismail-Beigi, Faramarz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531520/ https://www.ncbi.nlm.nih.gov/pubmed/31037553 http://dx.doi.org/10.1007/s13300-019-0619-1

Ejemplares similares

Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature
por: Rahimi, Leili, et al.
Publicado: (2020)

The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control
por: Yoshii, Hidenori, et al.
Publicado: (2022)

Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Taheri, Hoda, et al.
Publicado: (2020)

Associations between HbA(1c) and continuous glucose monitoring‐derived glycaemic variables
por: Hirsch, I. B., et al.
Publicado: (2019)

Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Chehrehgosha, Haleh, et al.
Publicado: (2021)

Relationship between HbA1c and Continuous Glucose Monitoring in Chinese Population: A Multicenter Study
por: Zhou, Jian, et al.
Publicado: (2013)

MON-086 Various Subcutaneous Continuous Glucose Monitors Comparably Lower HbA1c in Children
por: Gold, Steven, et al.
Publicado: (2020)

MON-625 Utility of Continuous Glucose Monitoring in Children with Type 1 Diabetes: Is HbA1c Enough?
por: Owens, Lindsey L, et al.
Publicado: (2020)

Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
por: Hashemi Madani, Nahid, et al.
Publicado: (2020)

Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial
por: Attaran, Fereshte, et al.
Publicado: (2023)

Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c<6%: a randomized controlled trial
por: Lai, Mengyu, et al.
Publicado: (2023)

The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes
por: Tsujino, Daisuke, et al.
Publicado: (2016)

Evaluation of continuous glucose monitoring‐derived person‐specific HbA1c in the presence and absence of complications in type 1 diabetes
por: Xu, Yongjin, et al.
Publicado: (2022)

Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept
por: Bent, Brinnae, et al.
Publicado: (2021)

The association between self-monitoring of blood glucose and HbA1c in type 2 diabetes
por: Yuan, Yanping, et al.
Publicado: (2023)

Beyond HbA(1c): Environmental Risk Factors for Diabetic Retinopathy
por: Nwanyanwu, Kristen Harris, et al.
Publicado: (2015)

SAT-126 The Relationship of Continuous Glucose Monitoring (CGM)-Derived Time-in-Range (TIR) to Hemoglobin A1c (HbA1c)
por: Vigersky, Robert, et al.
Publicado: (2019)

Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
por: Babaya, Naru, et al.
Publicado: (2021)

Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot study
por: Tokutsu, Akemi, et al.
Publicado: (2021)

ODP211 Impact of Race and Chronic Kidney Disease on the Correlation between HbA1c and Continuous Glucose Monitoring (CGM) Glycemic Measures
por: Kaplan, Leah, et al.
Publicado: (2022)

Accurate prediction of HbA1c by continuous glucose monitoring using a kinetic model with patient-specific parameters for red blood cell lifespan and glucose uptake
por: Xu, Yongjin, et al.
Publicado: (2021)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis
por: Aghili, Rokhsareh, et al.
Publicado: (2012)

An Evaluation of Point-of-Care HbA1c, HbA1c Home Kits, and Glucose Management Indicator: Potential Solutions for Telehealth Glycemic Assessments
por: Zaharieva, Dessi P., et al.
Publicado: (2022)

Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study
por: Dorcely, Brenda, et al.
Publicado: (2022)

Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes
por: Tyndall, Victoria, et al.
Publicado: (2019)

Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5)
por: Lameijer, A., et al.
Publicado: (2020)

Effect of the different assays of HbA1c on diabetic patients monitoring
por: Razi, Farideh, et al.
Publicado: (2015)

Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
por: Bae, Ji Cheol, et al.
Publicado: (2022)

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
por: Jeon, Ja Young, et al.
Publicado: (2013)

Effect of biological variation in HbA1c and blood glucose on the diagnosis of prediabetes
por: Hempe, James M., et al.
Publicado: (2023)

HbA1c and Glucose Management Indicator Discordance Associated with Obesity and Type 2 Diabetes in Intermittent Scanning Glucose Monitoring System
por: Fellinger, Paul, et al.
Publicado: (2022)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

HbA1c and retinal sensitivity in diabetics using microperimetry
por: Sharanjeet-Kaur, et al.
Publicado: (2019)

HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes
por: Stimson, Roland H, et al.
Publicado: (2020)

Improved HbA1c and reduced glycaemic variability after 1-year intermittent use of flash glucose monitoring
por: Zhang, Wenhui, et al.
Publicado: (2021)

Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c
por: Gallwitz, Baptist, et al.
Publicado: (2017)

Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore
por: Lim, Wei-Yen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mkhfdf0som370gpgtdrjvmnanf